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            In a quest for previously unknown aging-delaying (geroprotective) natural chemicals, we 
used a robust cell viability assay to conduct a screen of a library of commercially available plant 
extracts. Our screen was aimed at the identification of those plant extracts in the library that can 
significantly prolong the chronological lifespan of budding yeast. Many of the plant extracts in 
the library have been used in traditional Chinese and other herbal medicines or the 
Mediterranean and other customary diets. The screen allowed us to discover fifteen plant extracts 
that considerably extend the longevity of chronologically aging budding yeast not limited in 
calorie supply. We demonstrated that each of the fifteen longevity-extending plant extracts is a 
geroprotector that decreases both the extrinsic and the intrinsic rates of aging in budding yeast. 
Our findings provided evidence that each of the fifteen longevity-extending plant extracts makes 
yeast more resistant to chronic (long-term) oxidative and thermal stresses. We also revealed that 
each of the fifteen geroprotective plant extracts mimics the longevity-extending and stress-
protecting effects of a caloric restriction diet in yeast cells that are not limited in calorie supply 







I would like to thank my supervisor Dr. Titorenko for his continuous guidance and support 
throughout my graduate studies in his laboratory. I would also like to thank my committee 
members Dr. Madoka Gray-Mitsumune and Dr. Alisa Piekny for their valuable suggestions that 
contributed to my research and learning experience, as well as current and past members of the 
























Table of Contents 
 
Abstract                                                                                                                                           iii 
Acknowledgments                                                                                                                          iv 
Table of Content                                                                                                                              v 
List of Figures                                                                                                                                vii 
List of Tables                                                                                                                                  ix 
List of Abbreviations                                                                                                                       x              
1 Introduction                                                                                                                       1 
1.1 Studies in the budding yeast Saccharomyces cerevisiae discovered mechanisms of         1      
cellular processes that are common to all eukaryotes    
1.2  Two different methods of investigating S. cerevisiae aging in laboratory settings          1                                                                                                                                                                                                                                                                          
1.3  S. cerevisiae is a valuable model organism for uncovering mechanisms of cellular          3 
aging and longevity regulation in other eucaryotes                                                                                                            
1.4  Phytochemicals produced by plants slow aging and prolong the longevity of                   8 
S. cerevisiae                                                                                                                                                                                                                                                 
1.5  The objectives of studies described in this thesis                                                              10                                                                                                  
 
2 Materials and Methods                                                                                                    11 
2.1  Yeast strains, media and growth conditions                                                                      11 
2.2 Chronological lifespan (CLS) assay                                                                                  11 
2.3 Plating assays for the analysis of resistance to oxidative and thermal stresses                 12 
2.4 Statistical analysis                                                                                                              12 
 
3 Results                                                                                                                               13 
3.1  Identification of new PEs that prolong the longevity of chronologically aging  
            budding yeast                                                                                                                     13 
3.2 Each of the fifteen longevity-prolonging PEs mimics longevity extension by CR           28 
3.3 Each of the fifteen longevity-prolonging PEs is a geroprotector that decreases  
            both the extrinsic and the intrinsic rates of aging in budding yeast                                   32 
3.4 Each of the fifteen geroprotective PEs increases cell resistance to long-term  




4 Discussion                       35
                                                    
5 References                      39 























List of Figures 
 
Figure 1.1 Laboratory assays for measuring the replicative and chronological                        4  
lifespans under controllable conditions 
Figure 1.2 Several signalling pathways and protein kinases are integrated into                       5 
a network that controls the rate of yeast chronological aging and defines  
yeast longevity 
Figure 3.1 PE26, PE39 and PE42, but not PE38, PE40, PE41, PE43 or PE44, increase        19 
the mean and maximum CLS of WT yeast cultured under non-CR conditions  
on 2% (w/v) glucose 
Figure 3.2  PE47, but not PE45, PE46, PE48, PE49, PE50, PE51 or PE52, increases           20 
the mean and maximum CLS of WT yeast cultured under non-CR conditions  
on 2% (w/v) glucose 
Figure 3.3  PE59, but not PE53, PE54, PE55, PE56, PE57, PE58 or PE60, increases            21 
the mean and maximum CLS of WT yeast cultured under non-CR conditions  
on 2% (w/v) glucose 
Figure 3.4 PE64 and PE68, but not PE61, PE62, PE63, PE65, PE66 or PE67, increase        22  
the mean and maximum CLS of WT yeast cultured under non-CR conditions  
on 2% (w/v) glucose  
Figure 3.5  PE69, PE72 and PE75, but not PE70, PE71, PE73, PE74 or PE76, increase        23  
the mean and maximum CLS of WT yeast cultured under non-CR conditions  
on 2% (w/v) glucose 
Figure 3.6  PE77, PE78, PE79, PE81 and PE83, but not PE80, PE82 or PE84, increase        24  
the mean and maximum CLS of WT yeast cultured under non-CR conditions  
on 2% (w/v) glucose 
Figure 3.7  Neither PE85, PE86, PE87, PE88 nor PE89 can increase the mean or                 25 
maximum CLS of WT yeast cultured under non-CR conditions on  
2% (w/v) glucose 
Figure 3.8 0.5% (w/v) PE26, 0.5% (w/v) PE39, 0.5% (w/v) PE42, 0.3% (w/v) PE47,          26 
0.3% (w/v) PE59, 0.1% (w/v) PE64, 0.5% (w/v) PE68 and 1.0% (w/v) PE69 
exhibit the highest extending effects on the chronological lifespan (CLS) of  
viii 
 
wild-type (WT) yeast cultured under non-CR conditions on 2% (w/v) glucose             
Figure 3.9 0.1% (w/v) PE72, 0.3% (w/v) PE75, 0.5% (w/v) PE77, 0.3% (w/v) PE78,          27 
0.5% (w/v) PE79, 0.3% (w/v) PE81 and 0.5% (w/v) PE83 exhibit the highest 
extending effects on the CLS of WT yeast cultured under non-CR conditions on 
2% (w/v) glucose 
Figure 3.10 0.5% (w/v) PE26, 0.5% (w/v) PE39, 0.5% (w/v) PE42, 0.3% (w/v) PE59           29 
and 0.5% (w/v) PE68 (but not 0.3% (w/v) PE47, 0.1% (w/v) PE64 or 1.0% (w/v) 
PE69) extend the CLS of WT yeast cultured under CR conditions on 0.5% (w/v) 
glucose 
Figure 3.11 0.3% (w/v) PE78 and 0.5% (w/v) PE83 (but not 0.1% (w/v) PE72,                     30 
0.3% (w/v) PE75, 0.5% (w/v) PE77, 0.5% (w/v) PE79 or 0.3% (w/v) PE81) 
extend the CLS of WT yeast cultured under CR conditions on 0.5% (w/v)  
glucose 
Figure 3.12 Each of the fifteen PEs extends the longevity of chronologically aging yeast      31  
under non-CR conditions on 2% (w/v) glucose significantly more efficiently  
than it does under CR conditions on 0.5% (w/v) glucose 
Figure 3.13  Each of the fifteen geroprotective PEs makes yeast more resistant to chronic     33 

















List of Tables 
 
Table 3.1  Properties of plant extracts (PEs) used to conduct a new screen for PEs that       13 































List of Abbreviations 
 
ATG, autophagy; CFU, colony-forming units; CLS, chronological lifespan; CR, caloric 
restriction; non-CR, non-caloric restriction; PKA, protein kinase A; RLS, replicative lifespan; 
PKH1/2, Pkb-activating kinase homolog; ROS, reactive oxygen species; Sch9, serine-threonine 
protein kinase Sch9; SNF1, sucrose non-fermenting; TORC1, the target of rapamycin complex 1; 







1.1 Studies in the budding yeast Saccharomyces cerevisiae discovered mechanisms of 
cellular processes that are common to all eukaryotes  
            The budding yeast S. cerevisiae is a useful model for elucidating mechanisms that underlie 
various cellular processes in eukaryotic organisms across species. S. cerevisiae is a single-cellular 
eukaryotic organism that people used in winemaking, brewing and baking over the last ten 
thousand years [1-3]. Since the discovery of alcoholic yeast fermentation and because of the 
significant improvement of the genetics approaches for studying S. cerevisiae [4, 5], this fast-
growing under controllable culturing conditions unicellular eukaryote has also been used 
extensively as a model organism for elucidating the molecular mechanisms of many cellular 
processes [2, 6-8]. These cellular processes include the critical pathways of primary and secondary 
metabolism, DNA replication, DNA damage and repair, cell cycle regulation, vesicular protein 
traffic, transcription and translation mechanisms, cytoskeleton organization and function, 
mitochondrial respiration and oxidative phosphorylation, cellular signal transduction, cellular 
proteostasis maintenance, autophagy, lipid metabolism and transport, and many others [2, 6-10]. 
The rapid progress in using S. cerevisiae as a model organism in molecular biological studies of 
complex cellular processes was further speeded up after its genome was sequenced entirely, and 
the commercial libraries of gene-deletion, gene-overexpression and protein-tagging mutants of 
various genes became available [2, 7, 8, 10-13]. This progress was enhanced even more with the 
development and application of high-throughput methods for chemical biological, system 
biological and microfluidic dissection analyses of cellular processes in budding yeast [6-8, 10, 14-
16]. The subsequent studies in multicellular eukaryotes have convincingly demonstrated that the 
molecular mechanisms underlying many cellular processes and initially discovered in budding 
yeast operate similarly in other eukaryotic organisms [6-8, 10, 17-19]. Such a great extent of 
evolutionary conservation further emphasizes the importance of using S. cerevisiae as a model 
organism for uncovering the mechanistic basis of essential cellular processes. 
 
1.2 Two different methods of investigating S. cerevisiae aging in laboratory settings 
            Aging of S. cerevisiae under the controllable laboratory conditions can be investigated in 




is a tradition to use robust laboratory assays for examining each of these two modes of cellular 
aging separately from each other [20-23]. These two different modes are called the replicative and 
chronological modes of yeast aging.        
            S. cerevisiae reproduces by asymmetric cell divisions called buddings [21, 23]. In the 
laboratory assay for yeast replicative aging, every new daughter cell formed by budding from a 
mother cell is removed with the help of a micromanipulator and the maximal number of daughter 
cells that each mother cell can form before irreversibly exiting mitosis is counted (Figure 1.1) [21, 
23]. Thus, the maximal number of the mitotic divisions that a yeast cell can undergo before 
becoming mitotically senescent (i.e., incapable of dividing) defines the replicative mode of S. 
cerevisiae aging under laboratory conditions (Figure 1.1) [21, 23]. It is commonly believed that 
the replicative mode of yeast aging mimics the aging of mitotically active mammalian cells that 
can undergo only a limited number of divisions before becoming unable to divide [24-27]. 
Emerging evidence supports the notion that the replicative mode of yeast aging can be also be 
considered as a model for the aging of post-mitotic tissues in the nematode Caenorhabditis elegans 
and the organismal aging in humans [28-30]. Indeed, many genes that influence the replicative 
lifespan in S. cerevisiae also affect the reproductive lifespan in C. elegans [28, 29]. Furthermore, 
the hallmark events characteristic of replicatively old yeast cells are very similar to the ones 
observed in cells of elderly human individuals [30].   
            After S. cerevisiae cells cultured under laboratory conditions in a liquid medium with 
glucose consume this exogenous carbon source, they undergo a cell-cycle arrest in the G1 phase 
and enter a reversible G0 state of quiescence [20, 22]. Two characteristics of quiescent yeast cells 
distinguish them from non-quiescent cells. First, a quiescent yeast cell can form a colony after 
being transferred from a nutrient-depleted liquid medium to a surface of a nutrient-rich solid 
medium [20, 22]. Second, a population of quiescent yeast cells can synchronously re-enter the 
mitotic cell cycle after being transferred from a nutrient-depleted liquid medium to a nutrient-rich 
liquid medium [20, 22]. Under the laboratory conditions, a yeast cell in a nutrient-depleted liquid 
medium can maintain quiescence only for a limited number of days [20, 22]. Following this limited 
number of days, the S. cerevisiae cell exits quiescence and enters an irreversible state of mitotic 
senescence [20, 22]. The mitotically senescent yeast cells ultimately undergo an apoptotic or 
necrotic mode of regulated death [20, 22, 31, 32]. A laboratory clonogenic assay for yeast 




being quiescent to becoming senescent (Figure 1.1) [20, 22, 31, 32]. Hence, the number of days 
during which a yeast cell undergoes a transition from quiescence to senescence defines the 
chronological mode of S. cerevisiae aging under laboratory conditions (Figure 1.1) [20, 22]. It is 
generally accepted that the chronological mode of yeast aging mimics the aging of mitotically 
inactive mammalian cells that lost the ability to proliferate by growth and division [25, 26, 33, 34].     
            The above two methods have been employed to investigate the replicative and 
chronological modes of yeast aging separately from each other and under controllable laboratory 
conditions. Such conditions may differ substantially from those existing within various natural 
ecosystems inhabited by budding yeast. Recent findings indicate that the replicatively old yeast 
cells are also chronologically old and, thus, that an aging process of yeast residing in the wild may 
integrate the replicative and chronological modes of aging [35-40]. A challenge for the future is to 
investigate the aging process of budding yeast within natural ecosystems and/or under field-like 
laboratory conditions.  
 
1.3 S. cerevisiae is a valuable model organism for uncovering mechanisms of cellular 
aging and longevity regulation in other eucaryotes 
            As discussed above, the replicative and chronological lifespans of budding yeast are both 
relatively short and easy to measure under controllable laboratory conditions [20-23]. Besides (as 
was also discussed above), many advanced molecular and cell biological approaches for 
investigating mechanisms of aging and other complex cellular processes have been developed for 
S. cerevisiae [6-8, 10, 14-16]. These two factors facilitate the discoveries of the key molecular 
players in the replicative and chronological modes of aging in budding yeast. Because the research 
topic of my thesis concerns yeast chronological aging, I will mainly discuss this mode of yeast 
aging further in the text.    
            Research on chronological aging of S. cerevisiae led to the discovery of many genes and 
their protein products that control the rate of chronological aging and regulate longevity of budding 
yeast (Figure 1.2) [17, 25, 41, 42].  
            Studies in budding yeast also revealed a distinct set of cellular processes that are essential 
contributors to the pace of yeast chronological aging and define the longevity of chronologically 
aging S. cerevisiae [17, 25, 41, 42]. These processes include protein synthesis in the cytosol and 




glyoxylate metabolic cycle, gluconeogenesis, glycogen synthesis and degradation, amino acid and 
fatty acid synthesis, autophagy, and peroxisome biogenesis (Figure 1.2) [17, 25, 41, 42].   
   
 
Figure 1.1. Laboratory assays for measuring the replicative and chronological lifespans 
under controllable conditions. A laboratory assay for replicative yeast aging measures the 
maximal number of mitotic divisions that a mother cell can undergo by budding a daughter cell 
before irreversibly exiting mitosis. A laboratory clonogenic assay for yeast chronological aging 
measures the number of days that are required for a quiescent cell to become senescent. See the 
text for more details.  
 
            Also, aging research in S. cerevisiae revealed specific signaling pathways and protein 
kinases that control the longevity-defining cellular processes [17, 25, 41, 42].  It was discovered 
that these signaling pathways and protein kinases are integrated into a hierarchical network (Figure 
1.2) [17, 25, 41, 42]. The network assimilates the pro-aging (further referred to also as “aging-
accelerating”) TORC1 (target of rapamycin complex 1) pathway, pro-aging PKA (protein kinase 
A) pathway, pro-aging PKH1/2 (Pkb-activating kinase homolog) pathway, anti-aging (further 
referred to also as “aging-decelerating” or “aging-delaying”) SNF1 (sucrose non-fermenting) 
pathway, anti-aging ATG (autophagy) pathway, pro-aging protein kinase Sch9 and anti-aging 
protein kinase Rim15 (Figure 1.2) [17, 25, 41, 42].   





Figure 1.2. Several signaling pathways and protein kinases are integrated into a network 
that controls the rate of yeast chronological aging and defines yeast longevity. This network 
controls longevity-defining cellular processes shown in the boxes. Activation arrows and 
inhibition bars indicate pro-aging processes (presented in blue color) or anti-aging processes 
(shown in red color). Pro-aging or anti-aging signaling pathways and protein kinases are shown in 
blue or red color, respectively. Please see the text for additional details. Abbreviations: ATG, 
autophagy; PKA, protein kinase A; PKH1/2, Pkb-activating kinase homologs 1 and 2; Rim15, an 
anti-aging protein kinase; Sch9, a pro-aging protein kinase; SNF1, sucrose non-fermenting protein 
1; TORC1, the target of rapamycin complex 1. 
 
            The pro-aging TORC1 pathway and its downstream target, the pro-aging protein kinase 
Sch9, are activated in response to the excessive amounts of nitrogen-rich nutrients (ammonium 
sulfate and amino acids) in a growth medium [17, 25, 41, 42]. Mutations that impair the 
functionalities of TORC1 or Sch9 delay yeast chronological aging and extend chronological 
lifespan in budding yeast [17, 25, 41, 42]. Furthermore, rapamycin-, caffeine- or cryptotanshinone-
dependent inhibition of TORC1 has aging-delaying and longevity-extending effects in 
chronologically aging S. cerevisiae [17, 25, 41, 42]. After being activated by an excessive supply 
of nitrogen-rich nutrients, TORC1 and Sch9 accelerate chronological aging and shorten the 
chronological lifespan of S. cerevisiae because they phosphorylate and inhibit proteins involved 
in several anti-aging cellular processes [17, 25, 41, 42].  These anti-aging processes include the 




[17, 25, 41, 42]. Besides, after being activated in response to excessive supply of nitrogen-
containing nutrients, TORC1 and Sch9 phosphorylate and stimulate the pro-aging cellular process 
of protein synthesis in the cytosol (Figure 1.2) [17, 25, 41, 42]. Another downstream target of 
TORC1 and Sch9 is the anti-aging protein kinase Rim15. After being subjected to the Sch9-
dependent phosphorylation and inhibition, the ability of Rim15 to stimulate the ant-aging process 
of cellular stress protection declines (Figure 1.2) [17, 25, 41, 42].       
            Sch9 is not the only phosphorylation target of activated TORC1 in budding yeast. The other 
TORC1 target is the anti-aging SNF1 pathway (Figure 1.2) [17, 25, 41, 42]. After being subjected 
to the TORC1-driven inhibitory phosphorylation, SNF1 less intensively promotes the anti-aging 
processes of mitochondrial respiration, glyoxylate cycle in mitochondria and the cytosol, 
gluconeogenesis in the cytosol, cytosolic glycogen synthesis, peroxisome biogenesis and 
autophagy in vacuoles (Figure 1.2) [17, 25, 41, 42]. The TORC1-driven phosphorylation of SNF1 
also suppresses its ability to inhibit the pro-aging cellular processes of amino acids synthesis in 
mitochondria and the cytosol, fatty acid synthesis in the cytosol and cytosolic glycogen 
degradation (Figure 1.2) [17, 25, 41, 42].      
            Yet, another inhibitory phosphorylation target of activated TORC1 is the aging-delaying 
process of autophagy. After activated TORC1 phosphorylates several proteins implicated in the 
autophagic degradation of damaged proteins and organelles, the intensity of such degradation 
declines, cellular proteostasis is weakened and the process of yeast chronological aging is 
accelerated (Figure 1.2) [17, 25, 41, 42].            
            The essential role of TORC1 in the acceleration of cellular and organismal aging has been 
conserved in the course of evolution. Indeed, the mechanistic target of rapamycin TOR complexes 
1 (mTORC1) and 2 (mTORC2) promote aging in nematodes, fruit flies, laboratory rodents and 
non-human primates because they phosphorylate and inhibit an evolutionarily conserved set of 
aging-decelerating cellular processes and phosphorylate and activate a set of aging-accelerating 
cellular processes similar to the ones subjected to activating phosphorylation in budding yeast 
(Figure 1.2) [17, 25]. 
            The pro-aging protein kinase Sch9 is a downstream activating phosphorylation target not 
only for TORC1 but also for the sphingolipid long-chain base-activated PKH1/2 pathway in 
budding yeast (Figure 1.2) [17, 25, 41, 42]. In response to an increase in the concentration of 




phosphorylation of Sch9, thus initiating the Sch9-dependent activation of pro-aging cellular 
processes and inhibition of anti-aging cellular processes in budding yeast  (Figure 1.2) [17, 25, 41, 
42]. Noteworthy, mutations that impair the functionality of the Pkh1 and Pkh2 protein components 
of the PKH1/2 pathway or cell treatment with myriocin (an indirect inhibitor of this pathway) slow 
down aging and prolong lifespan in chronologically aging S. cerevisiae [17, 25, 41, 42].     
            The longevity regulation network depicted in Figure 1.2 also integrates the pro-aging PKA 
pathway [17, 25, 41, 42]. This pathway is activated when yeast cells are cultured in a medium 
initially containing high concentrations of glucose [17, 25, 41, 42]. Mutations that impair the 
functionality of several protein components of the PKA pathway slow down yeast chronological 
aging and prolong chronological lifespan in budding yeast [17, 25, 41, 42]. The activated PKA 
pathway accelerates yeast chronological aging and shortens yeast chronological lifespan because 
it elicits the inhibitory phosphorylation of Rim15, thus weakening the aging-delaying process of 
cellular stress protection (Figure 1.2) [17, 25, 41, 42]. The activated PKA pathway also promotes 
aging and decreases the longevity of chronologically aging yeast by promoting activating 
phosphorylation of proteins involved in the aging-accelerating process of protein translation in the 
cytosol (Figure 1.2) [17, 25, 41, 42]. The PKA pathway is an essential contributor to longevity 
regulation not only in budding yeast but also in laboratory mice [17, 25]. Hence, the essential role 
of the PKA pathway in accelerating cellular and organismal aging has been conserved in the course 
of evolution. 
            Moreover, studies in budding yeast discovered several small chemical molecules that slow 
yeast chronological aging and prolong yeast longevity because they control the information flow 
through the signaling network of longevity regulation [17, 25, 41, 42]. These molecules include 
resveratrol, rapamycin, caffeine, myriocin, spermidine, cryptotanshinone, quercetin and 
lithocholic bile acid [17, 25, 41, 42]. Although resveratrol increases the replicative lifespan of 
budding yeast because it stimulates the NAD+-dependent protein deacetylase Sir2, it extends yeast 
chronological lifespan in a Sir2-independent manner – perhaps by activating some other NAD+-
dependent protein deacetylases [17, 25, 41, 42]. The longevity-extending abilities of rapamycin, 
caffeine and cryptotanshinone in chronologically aging yeast are due to their direct (rapamycin 
and caffeine) or indirect (cryptotanshinone) inhibitory effects on TORC1 [17, 25, 41, 42]. 
Myriocin extends yeast chronological lifespan because it indirectly inhibits the Pkh1 and Pkh2 




lifespan of budding yeast because it stimulates transcription of genes encoding proteins that 
involve in the aging-decelerating process of autophagy [17, 25, 41, 42]. Quercetin extends the 
chronological lifespan of budding yeast by causing a significant decline in the intracellular 
concentration of reactive oxygen species (ROS), thereby protecting cellular macromolecules from 
oxidative damage [17, 25, 41, 42]. Lithocholic bile acid increases yeast chronological lifespan 
because it alters the mitochondrial membrane lipidome, thereby improving mitochondrial 
functionality [17, 25, 41, 42]. 
            After all these genes, proteins, cellular processes, signaling pathways, protein kinases and 
small chemical molecules were discovered in chronologically aging yeast, aging research in 
several multicellular eukaryotic organisms (including the nematode Caenorhabditis elegans, the 
fruit fly Drosophila melanogaster, laboratory rodents and non-human primates) revealed that 
similar genes, proteins, cellular processes, signaling pathways, protein kinases and small chemical 
molecules control the rates of cellular and organismal aging and regulate organismal lifespan and 
healthspan in these eukaryotes. These findings provided evidence that mechanisms of aging and 
aging delay have been conserved in the evolution [8, 10, 17-19, 25-27, 29, 30, 41, 42]. Thus, S. 
cerevisiae is a useful model organism for uncovering these evolutionarily conserved mechanisms.               
 
1.4 Phytochemicals produced by plants slow aging and prolong the longevity of S. 
cerevisiae 
            Plants synthesize phytochemicals as the products of secondary metabolic pathways that, 
unlike the primary metabolic pathways, do not provide the host plants with significant amounts of 
energy or abundant quantities of biosynthetic products needed for their growth and reproduction 
[43-45]. Based on the chemical structure and functionality of phytochemicals, they belong to 
eleven different classes. These chemical classes of phytochemicals include phenolic compounds, 
terpenes, betalains, polysulfides, organosulfides, indoles, protease inhibitors, organic acids, 
modified purines, quinones and polyamines [46-48].  
            It has been proposed that plants evolved the secondary metabolic pathways for the 
synthesis of phytochemicals because these diverse chemical compounds can help the host plants 
to survive and reproduce [49-56]. The survival and reproduction benefits that phytochemicals 




defense from invading insects and many viral and microbial infections, and an attraction of 
pollinators and other symbiotes [49-56].  
            In addition to the above benefits that phytochemicals provide to the host plants, they are 
known for their abilities to slow cellular aging and prolong longevity in budding yeast [57-62]. 
            Resveratrol is a polyphenolic phytochemical that increases the replicative lifespan of 
budding yeast because it stimulates the NAD+-dependent protein deacetylase called Sir2 [57]. The 
resveratrol-dependent stimulation of Sir2 suppresses rDNA recombination, thereby enhancing the 
stability of nuclear DNA and extending the longevity of replicatively aging S. cerevisiae [57].  
            Quercetin is a flavonoid phytochemical compound that extends the longevity of 
chronologically aging budding yeast because it elicits a significant decline in the intracellular level 
of ROS, thus lowering the extent of glutathione oxidation, lipid peroxidation and protein 
carbonylation [58]. These quercetin-driven changes increase cell resistance to oxidative stress, thus 
slowing down the chronological aging of S. cerevisiae [58].     
            Caffeine is a purine-like phytochemical compound that slows the chronological mode of 
yeast aging by inhibiting the protein kinase activity of TORC1, thus stimulating the aging-delaying 
cellular processes and suppressing the aging-accelerating cellular processes described in section 
1.3. The aging-delaying cellular processes that are stimulated by the caffeine-dependent inhibition 
of TORC1 include the maintenance of nuclear genome stability, protein synthesis in mitochondria, 
cellular stress protection, mitochondrial respiration, glyoxylate cycle in mitochondria and the 
cytosol, gluconeogenesis in the cytosol, cytosolic glycogen synthesis, peroxisome biogenesis, 
autophagy and cellular proteostasis maintenance (Figure 1.2) [17, 25, 41, 42, 59]. The aging-
accelerating cellular processes that are suppressed in response to the caffeine-dependent inhibition 
of TORC1 include protein synthesis in mitochondria, amino acids synthesis in mitochondria and 
the cytosol, fatty acid synthesis in the cytosol and cytosolic glycogen degradation (Figure 1.2) [17, 
25, 41, 42].       
            Spermidine is a polyamine phytochemical compound that prolongs the chronological 
lifespan oh S. cerevisiae because it promotes the deacetylation of histone H3 by inactivating 
histone acetyltransferases [83]. The spermidine-dependent deacetylation of histone H3 promotes 
transcription of several autophagy-related genes, thus enhancing autophagic removal of 
dysfunctional organelles, promoting cellular proteostasis and delaying the onset of an age-related 




            Phloridzin is a polyphenolic phytochemical compound that increases the replicative 
lifespan of S. cerevisiae because it promotes transcription of the genes for the cytosolic and 
mitochondrial forms of superoxide dismutase (Sod1 and Sod2, respectively) as well as for the 
NAD+-dependent protein deacetylase Sir2 [272]. The phloridzin-driven increase in the enzymatic 
activities of Sod1 and Sod2 suppresses the aging-accelerating process of oxidative macromolecular 
damage by reducing the intracellular levels of ROS [272]. The phloridzin-driven rise in the 
enzymatic activity of Sir2 inhibits rDNA recombination, thereby stimulating the aging-delaying 
process of nuclear DNA maintenance [272]. All these effects of phloridzin extend the replicative 
lifespan of budding yeast.   
             Cryptotanshinone is a quinone phytochemical compound that extends the chronological 
lifespan of S. cerevisiae because it elicits the following two effects: 1) it inhibits the pro-aging 
protein kinases TORC1 and Sch9, thus lowering the inhibitory phosphorylation of their numerous 
aging-decelerating protein targets and promoting the activating phosphorylation of their many 
aging-accelerating protein targets (see section 1.3), and 2) it activates mitochondrial superoxide 
dismutase Sod2, thus reducing the intracellular levels of ROS and suppressing the aging-
accelerating process of oxidative macromolecular damage [62].                
 
1.5 The objectives of studies described in this thesis  
            The objective of studies presented in my thesis was to apply a robust clonogenic assay to 
search for previously unknown aging-delaying (geroprotective) plant extracts that can extend the 
longevity of chronologically budding yeast. Many of these commercially available plant extracts 
have been used in traditional Chinese and other herbal medicines or the Mediterranean and other 
customary diets. However, none of them has been known for their ability to slow aging and prolong 
the organismal lifespan. My search discovered fifteen plant extracts that significantly extend the 
longevity of chronologically aging yeast not limited in calorie supply. I found that each of the 
fifteen longevity-extending plant extracts makes yeast cells resistant to long-term oxidative and 
thermal stresses. All findings described in my thesis were published in Oncotarget. 2020; 11:2182-
2203. Dr. Titorenko intellectually directed this project. He also corrected the first draft of my thesis 




2 Materials and methods 
 
2.1 Yeast strains, media and growth conditions 
            The wild-type (WT) strain Saccharomyces cerevisiae BY4742 (MAT his31 leu20 
lys20 ura30) and single-gene-deletion mutant strains in the BY4742 genetic background (all 
from Thermo Scientific/Open Biosystems) were grown in a synthetic minimal YNB medium 
(0.67% (w/v) Yeast Nitrogen Base without amino acids from Fisher Scientific; #DF0919-15-3) 
initially containing 2% (w/v) or 0.5% (w/v) glucose (#D16-10; Fisher Scientific), 20 mg/l L-
histidine (# H8125; Sigma), 30 mg/l L-leucine (#L8912; Sigma), 30 mg/l L-lysine (#L5501; 
Sigma) and 20 mg/l uracil (#U0750; Sigma), with a plant extract (PE) or without it. A stock 
solution of each PE in ethanol was made on the day of adding this PE to cell cultures. For each 
PE, the stock solution was added to growth medium with 2% (w/v) or 0.5% (w/v) glucose 
immediately following cell inoculation into the medium. In a culture supplemented with a PE, 
ethanol was used as a vehicle at the final concentration of 2.5% (v/v). In the same experiment, 
yeast cells were also subjected to ethanol-mock treatment by being cultured in growth medium 
initially containing 2% (w/v) or 0.5% (w/v) glucose and 2.5% (v/v) ethanol. Cells were cultured 
at 30oC with rotational shaking at 200 rpm in Erlenmeyer flasks at a “flask volume/medium 
volume” ratio of 5:1. 
 
2.2 Chronological lifespan (CLS) assay 
            A sample of cells was taken from a culture at a certain day following cell inoculation and 
PE addition into the medium. A fraction of the sample was diluted to determine the total number 
of cells using a hemacytometer. Another fraction of the cell sample was diluted, and serial dilutions 
of cells were plated in duplicate onto YEP medium (1% (w/v) yeast extract, 2% (w/v) peptone; 
both from Fisher Scientific; #BP1422-2 and #BP1420-2, respectively) containing 2% (w/v)  
glucose (#D16-10; Fisher Scientific) as carbon source. After 2 d of incubation at 30oC, the number 
of colony-forming units (CFU) per plate was counted. The number of CFU was defined as the 
number of viable cells in a sample. For each culture, the percentage of viable cells was calculated 
as follows: (number of viable cells per ml/total number of cells per ml) × 100. The percentage of 




2.3 Plating assays for the analysis of resistance to oxidative and thermal stresses 
            For the analysis of hydrogen peroxide (oxidative stress) resistance, serial dilutions (1:100 
to 1:105) of cells removed from each culture at various time-points were spotted onto two sets of 
plates. One set of plates contained a YP medium with 2% glucose alone, whereas the other set 
contained a YP medium with 2% glucose supplemented with 5 mM hydrogen peroxide. Pictures 
were taken after a 3-day incubation at 30oC. 
            For the analysis of thermal stress resistance, serial dilutions (1:100 to 1:105) of cells 
removed from each culture at various time-points were spotted onto two sets of plates containing 
the YP medium with 2% glucose. One set of plates was incubated at 30oC. The other set of plates 
was initially incubated at 60oC for 60 min and was then transferred to 30oC. Pictures were taken 
after a 3-day incubation at 30oC. 
 
2.4 Statistical analysis 
            Statistical analysis was performed using Microsoft Excel’s Analysis ToolPack-VBA. All 
data on cell survival are presented as mean ± SEM (n = 6). The p values for comparing the means 
of two groups using an unpaired two-tailed t-test were calculated with the help of the GraphPad 
Prism 7 statistics software. The logrank test for comparing each pair of survival curves was 
performed with GraphPad Prism 7. Two survival curves were considered statistically different if 






3.1 Identification of new PEs that prolong the longevity of chronologically aging budding 
yeast 
            In search of new aging-delaying (geroprotective) PEs, we performed a screen of fifty-three 
commercially available PEs. The origin and properties of these PEs are shown in Table 3.1. These 
PEs are believed to have positive effects on human health, and many of them have been used in 
traditional Chinese and other herbal medicines or the Mediterranean and other long-established 
diets. 
 
Table 3.1. Properties of plant extracts (PEs) used to conduct a new screen for PEs that can 
prolong the longevity of chronologically aging budding yeast. 
 
Abbreviated 
name of a PE 
The botanical 
name of a plant    
Plant part used 
to make a PE  
Properties of a PE A commercial 
source of a PE 
PE26 Serenoa repens Berry Extraction solvent: carbon 
dioxide. Extract ratio: 15:1. 
Composition: natural extract 





Herb Extraction solvent: alcohol (50-
70%), water (30-50%). Extract 
ratio: (8-12):1. Composition: 






Aerial parts Extraction solvent: ethanol (60-
80%), water (20-40%). Extract 






Resin Extraction solvent: methanol 
(80%), water (20%). Extract 






Root Extraction solvent: ethanol (70-
80%), water (20-30%). Extract 






Leaf Extraction solvent: water. 
Extract ratio: (3-10):1. 





Berry Extraction solvent: ethanol 
(30%), water (70%). Extract 







Leaf Extraction solvent: water. 
Extract ratio: 4:1. Composition: 
> 5% cynarin. 
Idunn 
Technologies 
PE45 Allium cepa L. Bulb skin Extraction solvent: ethanol 
(70%), water (30 %). Extract 
ratio: (20-25):1. Composition: > 






Flower Extraction solvent: ethanol 
(80%), water (20%). Extract 






Leaf Extraction solvent: ethanol 
(90%), water (10%). Extract 





sativus L. var. 
niger 
Root Extraction solvent alcohol (60-
80%), water (40-20%). Extract 






Leaf Extraction solvent: acetone. 
Extract ratio: (35-50):1. 






Root Extraction solvent: ethanol 
(50%), water (50%). Extract 






Herb Extraction solvent: ethanol 
(60%), water (40%). Extract 






Leaf Extraction solvent: aqueous 
alcohol. Extract ratio: 10:1. 





Bean Extraction solvent: aqueous 
alcohol. Extract ratio: 10:1. 
Composition: unknown.  
Idunn 
Technologies 
PE54 Allium sativum 
L. 
Bulb Extraction solvent: water. 
Extract ratio: 120:1. 
Composition: 4.5% alliin. 
Idunn 
Technologies 
PE55 Morus alba Leaf Extraction solvent: ethanol 
(70%), water (30%). Extract 








Flower Extraction solvent: ethanol, 
water. Extract ratio: unknown. 




PE57 Morus nigra Fruit Extraction solvent: ethanol, 






Bark  Extraction solvent: unknown. 
Extract ratio: (35-40):1. 





Herb Extraction solvent: ethanol 
(30%), water (70%). Extract 






Root Extraction solvent: ethanol, 







Root Extraction solvent: water, then 
ethanol (96%) and water (4%). 
Extract ratio: (22-27):1. 






Leaf Extraction solvent: ethanol (70-
80%), water (20-30%). Extract 






Root Extraction solvent: ethanol 
(60%), water (40%). Extract 
ratio: 15:1. Composition: 0.3-





PE64 Citrus sinensis Fruit Extraction solvent: unknown. 
Extract ratio: unknown. 





Root Extraction solvent: ethanol 
(65%), water (35%,). Extract 






Bark Extraction solvent: ethanol 
(70%), water (30%). Extract 






Fruit Extraction solvent: water. 









Whole plant Extraction solvent: unknown. 




PE69 Vitis vinifera Grape skin Extraction solvent: ethanol 
(30%), water (70%). Extract 




PE70 Vitis vinifera Grape Extraction solvent: water (4%), 
ethanol (96%). Extract ratio: 







Grape + Fruit Extraction solvent: water (5%), 
ethanol (95%). Extract ratio: 
(500-600):1. Composition: ≥ 





Whole plant Extraction solvent: unknown. 
Extract ratio: unknown. 




PE73 Oryza sativa 
fermented with 
Monascus 
purpureus yeast  
Fermented rice  Extraction solvent: unknown. 
Extract ratio: unknown. 






Leaf Extraction solvent: unknown. 
Extract ratio: 4:1. Composition: 





Root Extraction solvent: ethanol 
(75%), water (25%). Extract 
ratio: (5-7):1. Composition: ≥ 






Root Extraction solvent: unknown. 
Extract ratio: unknown. 







Seed Extraction solvent: ethanol 
(60%), water (40%). Extract 
ratio: (5-8):1. Composition: 





Root bark Extraction solvent: ethanol 
(50%), water (50%). Extract 
ratio: (10-12):1. Composition: 









Extraction solvent: ethanol 
(80%), water (20%). Extract 








Extraction solvent: water. 
Extract ratio: (16-20):1. 





Leaf Extraction solvent: ethanol (70-
80%), water (20-30%). Extract 




PE82 NA NA Na-RALA Powder, Sodium R-
lipoate (> 80 % Total R-lipoic 





Whole plant Extraction solvent: unknown. 




PE84 Vitis vinifera L. Seed Extraction solvent: ethanol, 
water. Extract ratio: unknown. 







Extraction solvent: unknown. 




PE86 Panax ginseng Root Extraction solvent: unknown. 






Whole plant Extraction solvent: unknown. 






Flower Extraction solvent: unknown. 




PE89 Curcuma L. Root Extraction solvent: unknown. 
Extract ratio: unknown. 
Composition: curcumin solid 




      
            To conduct the screen, we exploited a robust clonogenic cell viability assay for measuring 
yeast chronological lifespan (CLS) [63]. In this assay, the wild-type (WT) strain BY4742 was 
cultured in the synthetic minimal YNB medium initially containing 2% (w/v) glucose, as described 
in Materials and Methods. Cells of budding yeast cultured under such non-caloric restriction (non-
CR) conditions are known to age chronologically faster than the ones cultured under CR conditions 
on 0.2% (w/v) or 0.5% (w/v) glucose [25, 26, 42, 63]. 
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            At the time of cell inoculation into the culturing medium, we added each of the assessed 
PEs at a final concentration ranging from 0.02% (w/v) to 1.0% (w/v). We found that PE40, PE41, 
PE44, PE50, PE53, PE66, PE73, PE84, PE86 and PE87 do not affect the mean and maximum CLS 
of WT yeast if exogenously supplemented within this wide range of initial concentrations (Figures 
3.1-3.7). In contrast, PE38, PE43, PE45, PE46, PE48, PE49, PE51, PE52, PE54-PE58, PE60-
PE63, PE65, PE67, PE70, PE71, PE74, PE76, PE80, PE82, PE85, PE88 and PE89 were cytotoxic 
at certain concentrations; they decreased the mean and/or maximum CLS of WT yeast if used at 
the final concentrations in the 0.1 (w/v) to 1.0% (w/v) range (Figures 3.1-3.7). 
            Our screen revealed that fifteen of fifty-three tested PEs statistically significantly increase 
the mean and maximum CLS of WT yeast cultured under non-CR conditions on 2% (w/v) glucose 
(Figures 3.1-3.6; Figures 3.8-3.9). Each of these fifteen PEs extended the longevity of 
chronologically aging WT yeast if used within a specific concentration range and exhibited the 
highest longevity-extending effect at a certain concentration within this range (Figures 3.1-3.6). 
The following PEs exhibited the highest longevity-extending effect under non-CR conditions of 
cell culturing: 0.5% (w/v) PE26 from berries of Serenoa repens (Figures 3.1 and 3.8A), 0.5% (w/v) 
PE39 from aerial parts of Hypericum perforatum (Figures 2.1 and 2.8B), 0.5% (w/v) PE42 from 
leaves of Ilex paraguariensis (Figures 3.1 and 3.8C), 0.3% (w/v) PE47 from leaves of Ocimum 
tenuiflorum (Figures 3.1 and 3.8D), 0.3% (w/v) PE59 from the whole plant of Solidago virgaurea 
(Figures 3.1 and 3.8E), 0.1% (w/v) PE64 from fruits of Citrus sinensis (Figures 3.4 and 3.8F), 
0.5% (w/v) PE68 from the whole plant of Humulus lupulus (Figures 3.4 and 3.8G), 1.0% (w/v) 
PE69 from grape skins of Vitis vinifera (Figures 3.5 and 3.8H), 0.1% (w/v) PE72 from the whole 
plant of Andrographis paniculata (Figures 3.5 and 3.9A), 0.3% (w/v) PE75 from roots of Hydrastis 
canadensis (Figures 3.5 and 3.9B), 0.5% (w/v) PE77 from seeds of Trigonella foenum-graecum 
(Figures 3.6 and 3.9C), 0.3% (w/v) PE78 from root barks of Berberis vulgaris (Figures 3.6 and 
3.9D), 0.5% (w/v) PE79 from leaves, flowers and stems of Crataegus monogyna (Figures 3.6 and 
3.9E), 0.3% (w/v) PE81 from leaves of Taraxacum erythrospermum (Figures 3.6 and 3.9F), and 





Figure 3.1. PE26, PE39 and PE42, but not PE38, PE40, PE41, PE43 or PE44, increase the 
mean and maximum CLS of WT yeast cultured under non-CR conditions on 2% (w/v) 
glucose. WT cells were cultured in the synthetic minimal YNB medium initially containing 2% 
(w/v) glucose, in the presence of a PE or its absence. The mean and maximum lifespans of 
chronologically aging WT strain cultured under non-CR conditions without a PE or with a PE 
added at various concentrations are shown; data are presented as means ± SEM (n = 6; * p < 0.05, 
** p < 0.01, *** p < 0.001, ns, not significant; the p values for comparing the means of two groups 
were calculated using an unpaired two-tailed t test as described in Materials and Methods). Note 
that PE38 and PE43 can decrease the CLS of WT yeast under non-CR conditions if added at a final 




   
Figure 3.2. PE47, but not PE45, PE46, PE48, PE49, PE50, PE51 or PE52, increases the mean 
and maximum CLS of WT yeast cultured under non-CR conditions on 2% (w/v) glucose. 
WT cells were cultured as described in the legend to Figure 2.1. The mean and maximum lifespans 
of chronologically aging WT strain cultured under non-CR conditions without a PE or with a PE 
added at various concentrations are shown; data are presented as means ± SEM (n = 6; * p < 0.05, 
** p < 0.01, *** p < 0.001, ns, not significant; the p values for comparing the means of two groups 
were calculated as described in the legend to Figure 2.1). Note that PE45, PE46, PE48, PE49, PE51 
and PE52 can decrease the CLS of WT yeast under non-CR conditions if added at a final 





Figure 3.3. PE59, but not PE53, PE54, PE55, PE56, PE57, PE58 or PE60, increases the mean 
and maximum CLS of WT yeast cultured under non-CR conditions on 2% (w/v) glucose. 
WT cells were cultured as described in the legend to Figure 2.1. The mean and maximum lifespans 
of chronologically aging WT strain cultured under non-CR conditions without a PE or with a PE 
added at various concentrations are shown; data are presented as means ± SEM (n = 6; * p < 0.05, 
** p < 0.01, *** p < 0.001, ns, not significant; the p values for comparing the means of two groups 
were calculated as described in the legend to Figure 2.1). Note that PE54, PE55, PE56, PE57, PE58 
and PE60 can decrease the CLS of WT yeast under non-CR conditions if added at a final 





Figure 3.4. PE64 and PE68, but not PE61, PE62, PE63, PE65, PE66 or PE67, increase the 
mean and maximum CLS of WT yeast cultured under non-CR conditions on 2% (w/v) 
glucose. WT cells were cultured as described in the legend to Figure 2.1. The mean and maximum 
lifespans of chronologically aging WT strain cultured under non-CR conditions without a PE or 
with a PE added at various concentrations are shown; data are presented as means ± SEM (n = 6; 
* p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant; the p values for comparing the means 
of two groups were calculated as described in the legend to Figure 2.1). Note that PE61, PE62, 
PE63, PE65 and PE67 can decrease the CLS of WT yeast under non-CR conditions if added at a 





Figure 3.5. PE69, PE72 and PE75, but not PE70, PE71, PE73, PE74 or PE76, increase the 
mean and maximum CLS of WT yeast cultured under non-CR conditions on 2% (w/v) 
glucose. WT cells were cultured as described in the legend to Figure 2.1. The mean and maximum 
lifespans of chronologically aging WT strain cultured under non-CR conditions without a PE or 
with a PE added at various concentrations are shown; data are presented as means ± SEM (n = 6; 
* p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant; the p values for comparing the means 
of two groups were calculated as described in the legend to Figure 2.1). Note that PE70, PE71, 
PE74 and PE76 can decrease the CLS of WT yeast under non-CR conditions if added at a final 





Figure 3.6. PE77, PE78, PE79, PE81 and PE83, but not PE80, PE82 or PE84, increase the 
mean and maximum CLS of WT yeast cultured under non-CR conditions on 2% (w/v) 
glucose. WT cells were cultured as described in the legend to Figure 2.1. The mean and maximum 
lifespans of chronologically aging WT strain cultured under non-CR conditions without a PE or 
with a PE added at various concentrations are shown; data are presented as means ± SEM (n = 6; 
* p < 0.05, ** p < 0.01, *** p < 0.001, ns, not significant; the p values for comparing the means 
of two groups were calculated as described in the legend to Figure 2.1). Note that PE80 and PE82 
can decrease the CLS of WT yeast under non-CR conditions if added at a final concentration of 





Figure 3.7. Neither PE85, PE86, PE87, PE88 nor PE89 can increase the mean or maximum 
CLS of WT yeast cultured under non-CR conditions on 2% (w/v) glucose. WT cells were 
cultured as described in the legend to Figure 2.1. The mean and maximum lifespans of 
chronologically aging WT strain cultured under non-CR conditions without a PE or with a PE 
added at various concentrations are shown; data are presented as means ± SEM (n = 6; * p < 0.05, 
** p < 0.01, ns, not significant; the p values for comparing the means of two groups were calculated 
as described in the legend to Figure 2.1). Note that PE85, PE88 and PE89 can decrease the CLS 
of WT yeast under non-CR conditions if added at a final concentration ranging from 0.3% (w/v) 





Figure 3.8. 0.5% (w/v) PE26, 0.5% (w/v) PE39, 0.5% (w/v) PE42, 0.3% (w/v) PE47, 0.3% 
(w/v) PE59, 0.1% (w/v) PE64, 0.5% (w/v) PE68 and 1.0% (w/v) PE69 exhibit the highest 
extending effects on the chronological lifespan (CLS) of wild-type (WT) yeast cultured under 
non-CR conditions on 2% (w/v) glucose. WT cells were cultured in the synthetic minimal YNB 
medium initially containing 2% (w/v) glucose, in the presence of a PE or its absence. In the cultures 
supplemented with a PE, ethanol was used as a vehicle at a final concentration of 2.5% (v/v). In 
the same experiment, WT cells were also subjected to ethanol-mock treatment by being cultured 
in the synthetic minimal YNB medium initially containing 2% (w/v) glucose and 2.5% (v/v) 
ethanol. Survival curves (the upper panels in A-H) and the mean and maximum lifespans (the 
lower two panels in A-H) of chronologically aging WT cells cultured without a PE (cells were 
subjected to ethanol-mock treatment) or with a PE (which was added at the concentration optimal 
for CLS extension) are shown. Data are presented as means ± SEM (n = 6). In the upper panels in 
A-H, CLS extension was significant for each of the PEs tested (p < 0.05; the p values for comparing 
each pair of survival curves were calculated using the logrank test as described in Materials and 
Methods). In the lower two panels in A-H, *p < 0.05, **p < 0.01, ***p < 0.001; the p values for 
comparing the means of two in groups were calculated using an unpaired two-tailed t test as 
described in Materials and Methods). Data for mock-treated WT cells are replicated in graphs A-
H of this Figure. Data for WT cells cultured with a PE added at the concentration optimal for CLS 
extension are replicated in Figure 2.1 (for 0.5% (w/v) PE26, 0.5% (w/v) PE39 and 0.5% (w/v) 
PE42), Figure 2.2 (for 0.3% (w/v) PE47), Figure 2.3 (for 0.3% (w/v) PE59), Figure 2.4 (for 0.1% 




Figure 3.9. 0.1% (w/v) PE72, 0.3% (w/v) PE75, 0.5% (w/v) PE77, 0.3% (w/v) PE78, 0.5% 
(w/v) PE79, 0.3% (w/v) PE81 and 0.5% (w/v) PE83 exhibit the highest extending effects on 
the CLS of WT yeast cultured under non-CR conditions on 2% (w/v) glucose. WT cells were 
cultured in the synthetic minimal YNB medium initially containing 2% (w/v) glucose, in the 
presence of a PE or its absence. In the cultures supplemented with a PE, ethanol was used as a 
vehicle at a final concentration of 2.5% (v/v). In the same experiment, WT cells were also 
subjected to ethanol-mock treatment by being cultured in the synthetic minimal YNB medium 
initially containing 2% (w/v) glucose and 2.5% (v/v) ethanol. Survival curves (the upper panels in 
A-G) and the mean and maximum lifespans (the lower two panels in A-G) of chronologically aging 
WT cells cultured without a PE (cells were subjected to ethanol-mock treatment) or with a PE 
(which was added at the concentration optimal for CLS extension) are shown. Data are presented 
as means ± SEM (n = 6). In the upper panels in A-G, CLS extension was significant for each of 
the PEs tested (p < 0.05; the p values for comparing each pair of survival curves were calculated 
using the logrank test as described in Materials and Methods). In the lower two panels in A-G, *p 
< 0.05, **p < 0.01, ***p < 0.001; the p values for comparing the means of two in groups were 
calculated using an unpaired two-tailed t test as described in Materials and Methods). Data for 
mock-treated WT cells are replicated in graphs A-G of this Figure. Data for WT cells cultured with 
a PE added at the concentration optimal for CLS extension are replicated in Figure 1.4 (for 0.1% 
(w/v) PE72 and 0.3% (w/v) PE75) and Figure 2.6 (for 0.5% (w/v) PE77, 0.3% (w/v) PE78, 0.5% 




3.2 Each of the fifteen longevity-prolonging PEs mimics longevity extension by CR   
            CR without malnutrition is a low-calorie dietary regimen that extends lifespan in many 
evolutionarily distant organisms and improves healthspan in laboratory rodents and rhesus 
monkeys [17, 26, 64-66]. Certain natural chemicals and synthetic drugs have been shown to elicit 
the CR-like lifespan-extending and healthspan-improving effects even under non-CR conditions 
(i.e., when calorie supply is not limited) [67-72]. These natural and synthetic chemical compounds 
are called CR mimetics (CRMs) if they not only extend longevity under non-CR conditions but 
also if they exhibit three other effects. First, CRMs do not impair food intake. Second, CRMs have 
CR-like effects on metabolism and physiology. Third, akin to CR, CRMs decrease the 
susceptibility to diverse stresses [73, 74]. In the present study, we found that each of the fifteen 
longevity-extending PEs increases yeast CLS under non-CR conditions on 2% (w/v) glucose 
(Figures 3.1-3.6, Figures 3.8 and 3.9). Besides, our recent unpublished data revealed that none of 
the fifteen longevity-extending PEs compromises glucose intake during culturing under these 
conditions. Thus, it seems that all these PEs are CRMs. This conclusion is further supported by 
our observations that each of the fifteen longevity-extending PEs exhibits a CR-like effect on stress 
resistance (see below). 
            Of note, we previously reported that if the CR diet is administered by culturing yeast in the 
YNB medium initially containing 0.5% (w/v) glucose, it significantly increases both the mean and 
maximum CLS of S. cerevisiae [63]. In the present study, we investigated how each of the fifteen 
PEs that extends longevity under non-CR conditions influences the longevity of yeast cultured 
under CR conditions on 0.5% (w/v) glucose. We found that eight of the fifteen PEs that prolong 
the longevity of chronologically aging yeast under non-CR conditions do not increase either the 
mean or the maximum CLS of S. cerevisiae under CR conditions (Figures 3.10 and 3.11). These 
PEs included 0.3% (w/v) PE47 (Figure 3.10D), 0.1% (w/v) PE64 (Figure 3.10F), 1.0% (w/v) PE69 
(Figure 3.10H), 0.1% (w/v) PE72 (Figure 3.11A), 0.3% (w/v) PE75 (Figure 3.11B), 0.5% (w/v) 
PE77 (Figure 3.11C), 0.5% (w/v) PE79 (Figure 3.11E) and 0.3% (w/v) PE81 (Figure 3.11F). It 
seems conceivable, therefore, that each of these eight PEs increases yeast CLS because it 
modulates the same or highly overlapping sets of longevity-defining cellular processes under both 
CR and non-CR conditions. 
            We also revealed that seven of the fifteen PEs that extend yeast longevity under non-CR 
conditions also increase both the mean and maximum CLS of S. cerevisiae under CR conditions 
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(Figures 3.10 and 3.11). 0.5% (w/v) PE26 (Figure 3.10A), 0.5% (w/v) PE39 (Figure 3.10B), 0.5% 
(w/v) PE42 (Figure 3.10C), 0.3% (w/v) PE59 (Figure 3.10E), 0.5% (w/v) PE68 (Figure 3.10G), 
0.3% (w/v) PE78 (Figure 3.11D) and 0.5% (w/v) PE83 (Figure 3.11G)  were among these PEs. 
Therefore, we hypothesize that each of these seven PEs increases yeast CLS under CR conditions 
because it regulates the sets of longevity-defining cellular processes that differ from (or only 
partially overlap with) the ones it modulates under non-CR conditions. 
            We then compared the efficiency with which each of the fifteen PEs increases yeast CLS 
under non-CR conditions to that under CR conditions. Our comparison revealed that each of these 
PEs extends the longevity of chronologically aging yeast under non-CR conditions significantly 
more efficiently than it does under CR conditions (Figure 3.12). This finding shows that each of 
the fifteen PEs is a more effective longevity-prolonging intervention in chronologically aging yeast 
not-limited in calorie supply than it is in yeast placed on a CR diet. 
 
  
Figure 3.10. 0.5% (w/v) PE26, 0.5% (w/v) PE39, 0.5% (w/v) PE42, 0.3% (w/v) PE59 and 
0.5% (w/v) PE68 (but not 0.3% (w/v) PE47, 0.1% (w/v) PE64 or 1.0% (w/v) PE69) extend 
the CLS of WT yeast cultured under CR conditions on 0.5% (w/v) glucose. WT cells were 
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cultured in the synthetic minimal YNB medium initially containing 0.5% (w/v) glucose, in the 
presence of a PE or its absence. In the cultures supplemented with a PE, ethanol was used as a 
vehicle at a final concentration of 2.5% (v/v). In the same experiment, WT cells were also 
subjected to ethanol-mock treatment by being cultured in the synthetic minimal YNB medium 
initially containing 0.5% (w/v) glucose and 2.5% (v/v) ethanol. Survival curves (the upper panels 
in A-H) and the mean and maximum lifespans (the lower two panels in A-H) of chronologically 
aging WT cells cultured without a PE (cells were subjected to ethanol-mock treatment) or with a 
PE (which was added at the concentration optimal for CLS extension under non-CR conditions) 
are shown. Data are presented as means ± SEM (n = 6). In the upper panels in A-C, E and F, CLS 
extension was significant for each of the PEs tested (p < 0.05; the p values for comparing each pair 
of survival curves were calculated using the logrank test as described in Materials and Methods). 
In the lower two panels in A-C, E and F, **p < 0.01, ***p < 0.001; the p values for comparing the 
means of two in groups were calculated using an unpaired two-tailed t test as described in Materials 
and Methods). In the upper panels in D, F and H, CLS extension was statistically not significant 
for each of the PEs tested (the p values for comparing each pair of survival curves were calculated 
using the logrank test as described in Materials and Methods). In the lower two panels in D, F and 
H, ns, not significant; the p values for comparing the means of two in groups were calculated using 
an unpaired two-tailed t test as described in Materials and Methods). Data for mock-treated WT 




Figure 3.11. 0.3% (w/v) PE78 and 0.5% (w/v) PE83 (but not 0.1% (w/v) PE72, 0.3% (w/v) 
PE75, 0.5% (w/v) PE77, 0.5% (w/v) PE79 or 0.3% (w/v) PE81) extend the CLS of WT yeast 
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cultured under CR conditions on 0.5% (w/v) glucose. WT cells were cultured in the synthetic 
minimal YNB medium initially containing 0.5% (w/v) glucose, in the presence of a PE or its 
absence. In the cultures supplemented with a PE, ethanol was used as a vehicle at a final 
concentration of 2.5% (v/v). In the same experiment, WT cells were also subjected to ethanol-
mock treatment by being cultured in the synthetic minimal YNB medium initially containing 0.5% 
(w/v) glucose and 2.5% (v/v) ethanol. Survival curves (the upper panels in A-G) and the mean and 
maximum lifespans (the lower two panels in A-G) of chronologically aging WT cells cultured 
without a PE (cells were subjected to ethanol-mock treatment) or with a PE (which was added at 
the concentration optimal for CLS extension under non-CR conditions) are shown. Data are 
presented as means ± SEM (n = 6). In the upper panels in D and G, CLS extension was significant 
for each of the PEs tested (p < 0.05; the p values for comparing each pair of survival curves were 
calculated using the logrank test as described in Materials and Methods). In the lower two panels 
in D and G, **p < 0.01; the p values for comparing the means of two in groups were calculated 
using an unpaired two-tailed t test as described in Materials and Methods). In the upper panels in 
A-C, E and F, CLS extension was statistically not significant for each of the PEs tested (the p 
values for comparing each pair of survival curves were calculated using the logrank test as 
described in Materials and Methods). In the lower two panels in A-C, E and F, ns, not significant; 
the p values for comparing the means of two in groups were calculated using an unpaired two-
tailed t test as described in Materials and Methods). Data for mock-treated WT cells are replicated 




Figure 3.12. Each of the fifteen PEs extends the longevity of chronologically aging yeast 
under non-CR conditions on 2% (w/v) glucose significantly more efficiently than it does 
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under CR conditions on 0.5% (w/v) glucose. WT cells were cultured in the synthetic minimal 
YNB medium initially containing 2% (w/v) or 0.5% (w/v) glucose, in the presence of a PE or its 
absence. In the cultures supplemented with a PE, ethanol was used as a vehicle at a final 
concentration of 2.5% (v/v). In the same experiment, WT cells were also subjected to ethanol-
mock treatment by being cultured in the synthetic minimal YNB medium initially containing 0.5% 
(w/v) or 2% (w/v) glucose and 2.5% (v/v) ethanol. The extent to which each of the PE tested 
increases the mean (A) and maximum (B) CLS under non-CR and CR conditions were calculated 
based on the data presented in Figures 2.8-2.11. *p < 0.05, **p < 0.01, ***p < 0.001; the p values 
for comparing the means of two in groups were calculated using an unpaired two-tailed t test as 
described in Materials and Methods.  
 
3.3 Each of the fifteen longevity-prolonging PEs is a geroprotector that decreases both 
the extrinsic and the intrinsic rates of aging in budding yeast  
            Our data allow us to conclude that each of the fifteen longevity-prolonging PEs slows yeast 
chronological aging because it decreases both the extrinsic and the intrinsic rates of aging. This 
conclusion is based on our findings that each of these PEs extends both the mean and maximum 
CLS of yeast (Figures 3.10-3.12). The mean lifespans of evolutionarily distant organisms are 
thought to depend on specific environmental (extrinsic) factors to which cells are exposed before 
they enter the quiescent or senescent state [75, 76-78]. In contrast, the maximum lifespans of 
organisms across species are considered to rely on specific cellular and organismal longevity 
modifiers that operate after cells enter the quiescent or senescent state [75-77, 79, 80]. 
 
3.4 Each of the fifteen geroprotective PEs increases cell resistance to long-term oxidative 
and thermal stresses   
            Genetic, dietary and chemical interventions that decrease cell susceptibility to chronic 
(long-term) oxidative and/or thermal stresses have been shown to decelerate the aging process and 
extend longevity in yeast and other organisms across species [25, 26, 42]. Therefore, we 
investigated the effect of each of the fifteen geroprotective PEs on the susceptibility of 
chronologically aging yeast cells to these two types of chronic stresses.  
            To examine aging-associated changes in cell susceptibility to these long-term stresses, we 
recovered aliquots of yeast cells on days 1, 2, 3 and 4 of culturing under non-CR conditions in 
liquid YNB medium with 2% (w/v) glucose. To assess cell susceptibility to chronic oxidative 
stress, we spotted serial dilutions of these cell aliquots on solid YEP medium with 2% (w/v) 
glucose and 5 mM hydrogen peroxide and incubated them for 3 days. To assess cell susceptibility 
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to chronic thermal stress, we spotted serial dilutions of these cell aliquots on solid YEP medium 
with 2% (w/v) glucose, incubated at 60oC for 60 min, transferred the plates to 30oC and incubated 
at this temperature for 3 days. 
            We found that each of the fifteen geroprotective PEs makes yeast cells more resistant to 
chronic oxidative and thermal stresses, especially cells in ST-phase cultures recovered on days 3 
and 4 (Figures 3.13B and 3.13C, respectively). 
 
 
Figure 3.13. Each of the fifteen geroprotective PEs makes yeast more resistant to chronic 
(long-term) oxidative and thermal stresses. WT cells were cultured in the synthetic minimal 
YNB medium initially containing 2% (w/v) glucose, in the presence of a PE or its absence. In the 
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cultures supplemented with a PE, ethanol was used as a vehicle at a final concentration of 2.5% 
(v/v). In the same experiment, WT cells were also subjected to ethanol-mock treatment by being 
cultured in the synthetic minimal YNB medium initially containing 2% (w/v) glucose and 2.5% 
(v/v) ethanol. Spot assays for examining cell resistance to chronic oxidative (B) and thermal (C) 
stresses were performed as described in Materials and Methods. (A) In control samples, serial 10-
fold dilutions of cells recovered on different days of culturing were spotted on plates with solid 
YEP medium containing 2% (w/v) glucose. All pictures were taken after a 3-d incubation at 30oC. 
(B) In samples subjected to long-term oxidative stress, serial 10-fold dilutions of cells recovered 
on different days of culturing were spotted on plates with solid YEP medium containing 2% (w/v) 
glucose and 5 mM hydrogen peroxide. All pictures were taken after a 3-d incubation at 30oC. (C) 
In samples subjected to long-term thermal stress, serial 10-fold dilutions of cells recovered on 
different days of culturing were spotted on plates with solid YEP medium containing 2% (w/v) 
glucose, incubated at 60oC for 60 min and then transferred to 30oC. All pictures were taken after a 




4 Discussion  
            In search of new aging-delaying (geroprotective) PEs, we screened a library of PEs for 
extracts that can increase yeast CLS. This library includes 53 different PEs of known origin and 
properties. We discovered 15 PEs that extend the longevity of chronologically aging budding 
yeast. The high percentage (i.e., ~ 28%) of geroprotective PEs in this library was not surprising 
because our previous screen of a different set of 35 PEs from the same library led to the 
identification of 6 PEs exhibiting geroprotective effects [63]; thus, the percentage of geroprotective 
PEs discovered in this previous screen was ~ 17%. How to explain such high percentages of 
geroprotective PEs within the same library that was used for both screens? Two important aspects 
of these PEs origin and their geroprotective efficiencies need to be considered. First, it needs to be 
emphasized that the library includes mainly PEs known for their positive effects on human health 
because they have been for centuries used in traditional Chinese and other herbal medicines. 
Furthermore, some PEs from the library have been used in the Mediterranean and other long-
established diets. Second, it is important to note that each of the 15 geroprotective PEs identified 
here extends yeast CLS much more efficiently than any of the 42 individually added geroprotective 
compounds (either synthetic drugs or natural chemicals) known to prolong lifespan in budding and 
fission yeast as well as in other organisms [63]. These other organisms include filamentous fungi, 
nematodes, fruit flies, daphnias, mosquitoes, honeybees, fishes, mammals and cultured human 
cells [63]. Indeed, we found that under non-CR conditions, the 15 geroprotective PEs increase the 
mean and maximum CLS of S. cerevisiae by 140%-445% and 109%–460%, respectively (Figure 
3.12). Furthermore, the 6 geroprotective PEs that were discovered in the previous screen of the 
same library increase the mean and maximum CLS of yeast by 145%–475% and 80%–369%, 
respectively [63]. In contrast, any of the 42 presently known geroprotective compounds is known 
to prolong cellular and/or organismal lifespan in evolutionarily distant eukaryotes much less 
efficiently, within the 5% to 75% range, if it is applied individually [63]. 
            Considering the above two aspects of the origin and longevity-extending efficiencies of the 
15 geroprotective PEs that we discovered here (and of the 6 geroprotective PEs that were found 
earlier in a screen of the same library), we propose the following. It is possible that the high 
percentages of geroprotective PEs within the library used for both screens and the high longevity-
extending efficiencies of these geroprotectors was due to the presence of several geroprotective 
chemical compounds within each of the discovered PEs. We also propose that each of these 
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geroprotective chemical compounds may extend yeast CLS by targeting different signaling 
pathways and cellular processes contributing to longevity assurance in S. cerevisiae. Hence, both 
the high percentages of geroprotective PEs within the same library and the high longevity-
extending efficiencies of these PEs may be caused by the additive or synergistic longevity-
extending effects of the individual geroprotective chemical compounds that are present within each 
of the discovered PEs.  
            A similar idea of the additive or synergistic longevity-extending effects for the mixtures of 
individual geroprotective chemicals was proposed by others [92-96]. The following three multi-
component combinations of several chemical compounds were proposed in these studies as 
therapeutic geroprotective interventions. First, a three-component mixture was proposed. It 
contains epigallocatechin gallate (which is a known activator of cAMP synthesis), N-acetyl-L-
cysteine (which suppresses cell proliferation) and myricetin (which is known for its ability to 
stimulate integrin signaling pathway, DNA repair, cAMP synthesis and hypoxia-responsive 
signaling pathways) [92]. Second, a seven-component mixture of rapalogs (i.e.,  rapamycin and its 
synthetic chemical derivates that directly inhibits the aging-accelerating TORC1 pathway), 
metformin (which stimulates AMP-activated protein kinase (AMPK), a master regulator of 
glucose and lipid metabolism), losartan or lisinopril (both of which are known inhibitors of 
angiotensin II signaling), a statin (atorvastatin, simvastatin or lovastatin, all of which are known 
for their abilities to lower blood cholesterol concentrations), propranolol (which is known as a 
non-cardioselective beta-adrenergic antagonist), aspirin (which inhibits cyclooxygenase) and a 
phosphodiesterase 5 inhibitor, in combination with physical exercise and CR diet or intermittent 
fasting [94, 96]. Third, another three-component mixture was proposed. It includes rapamycin, 
acarbose (which inhibits α-glucosidase) and a cardiolipin-binding peptide [95]. 
            Considering the high longevity-extending efficiencies of all 21 discovered geroprotective 
PEs in budding yeast and the fact that the Health Canada government agency defines 19 of them 
[83] as the ones that are health-improving natural product safe for human consumption (see below 
for more details), it is not unreasonable to think that in the future some of them can be used to 
extend the lifespan and healthspan of humans. For each of them, Health Canada provides a detailed 
description of the source material, routes of administration, doses and dosage forms, uses or 
purposes, durations of use, risk information, cautions and warnings, contraindications, known 
adverse reactions, non-medicinal ingredients, specifications, references cited and reviewed, 
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examples of appropriate dosage preparations, and frequencies of use [83]. The ongoing 
collaboration between the Titorenko laboratory and Idunn Technologies Inc. addresses this 
challenge by investigating which of the discovered geroprotective PEs can increase the replicative 
lifespan of cultured human fibroblasts or improve the health of the ob/ob mice model of type II 
diabetes. 
            Certain natural chemicals and synthetic drugs have been shown to elicit the CR-like 
lifespan-extending and healthspan-improving effects even under non-CR conditions (i.e., when 
calorie supply is not limited) [67-72]. These natural and synthetic chemical compounds are called 
CR mimetics (CRMs) if they not only extend longevity under non-CR conditions but also if they 
exhibit three other effects. First, CRMs do not impair food intake [67-72]. Second, CRMs have 
CR-like effects on metabolism and physiology [97-102]. Third, akin to CR, CRMs decrease the 
susceptibility to diverse stresses [67-72]. Data presented in this Thesis and a recent article from 
the Titorenko laboratory [97] provide evidence that each of the 15 geroprotective PEs satisfies all 
the criteria previously proposed for a CRM. Indeed, each of these PEs increases yeast CLS under 
non-CR conditions on 2% (w/v) glucose and none of them compromises glucose intake during 
culturing under these conditions (this thesis and reference [97]). Furthermore, each of the 15 
geroprotective PEs exhibits CR-like effects on specific aspects of the metabolism and physiology 
of budding yeast [97]. These effects include an increased rate of coupled mitochondrial respiration 
and an altered chronology of changes in intracellular ROS concentrations [97]. ROS are mildly 
toxic cellular molecules known to play essential pro-hormetic roles in regulating the longevity of 
many evolutionarily distant organisms) [97]. These effects also include a decline in the oxidative 
damage to cellular proteins, membrane lipids and mitochondrial DNA [97]. Moreover, each of the 
15 geroprotective PEs makes yeast cells more resistant to long-term oxidative and thermal stresses 
(this thesis), likely because of the above effects of these PEs on intracellular ROS and oxidative 
macromolecular damage.  
            Of note, PE26, PE39, PE42, PE59, PE68, PE78 and PE83 can prolong yeast CLS even 
under CR conditions, when all cellular processes that limit longevity under non-CR conditions are 
likely to be suppressed. Therefore, it is possible that each of these 7 PEs may stimulate the 
longevity-extending cellular processes and/or may suppress the longevity-shortening cellular 
processes that operate only under CR conditions. Moreover, each of these 7 PEs may target both 
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CR-regulated and housekeeping (i.e., not regulated by CR) cellular processes (including cell 
susceptibility to long-term oxidative and thermal stresses).      
            Our goals for the future research of the 15 geroprotective PEs described here are outlined 
below. 
            First, we collaborate with Idunn Technologies Inc. in identifying chemical compounds that 
are responsible for the geroprotective effects of these PEs. Each of the 15 geroprotective PEs has 
already been fractionated with the help of the high-performance liquid chromatography on a C18 
reversed-phase column. We identified individual chromatography fractions capable of a 
statistically significant extension of yeast CLS. Chemical compounds present in these fractions 
will be identified by Idunn Technologies Inc. with the help of tandem mass spectrometry and 
nuclear magnetic resonance spectroscopy. It is possible that some of these chemical compounds 
are present in some (or even all) of the 15 geroprotective PEs, whereas others are unique to a 
particular PE.          
            Second, we are interested in investigating and understanding the molecular and cellular 
mechanisms through which each of these PEs slows yeast chronological aging. We have recently 
described mechanisms underlying the aging-delaying action of PE21 [91], an extract from the 
white willow Salix alba we discovered in our previous screen for geroprotective PEs [63]. 
            Third, we would like to explore how each of the 15 geroprotective PEs may coordinate the 
information flow through a longevity-defining network of signaling pathways and protein kinases 
operating in budding yeast and other organisms. This network incorporates the pro-aging TORC1, 
PKA and PKH1/2 pathways as well as the pro-aging serine/threonine-protein kinase Sch9 [17, 26, 
42, 81]. This network also integrates the anti-aging SNF1 and ATG pathways as well as the anti-
aging serine/threonine-protein kinase Rim15 [17, 26, 42, 81]. Our recent study has revealed that 
each of the 6 geroprotective PEs we discovered in the previous screen [63] slows yeast 
chronological aging through different functional modules of this longevity-defining signaling 
network [81]. Of note, pairwise mixes of these 6 geroprotective PEs slow the process of yeast 
chronological aging in a synergistic or additive manner only if they include the PEs that target 
different modules of this network [82]. Therefore, we are interested in investigating how different 
combinations of the 15 geroprotective PEs described here influence the extent of yeast 
chronological aging delay. We will be looking for the combinations of geroprotective PEs that 
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